HR 8857 United States House · 117th Congress

Generic Animal Drug Advancement Act

Summary
Generic Animal Drug Advancement Act This bill allows for the approval and corresponding labeling of generic animal drugs that are bioequivalent to another approved drug with respect to at least one species, rather than with respect to all of the same species. (Animal drugs are drugs that are intended for animals other than humans (e.g., pets and livestock). Animal drugs must be approved by the Food and Drug Administration before they may be offered on the commercial market.)
Bill status in committee 1 of 4 stages cleared
Introduction
Sep 2022
Committee Review
Floor Vote
President
Introduced Sep 15, 2022 Last action Sep 16, 2022
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
3
Key actions
0
Committee
2
Sep 16, 2022
Committee
Referred to the Subcommittee on Health.
lower
Sep 15, 2022
Committee
Referred to the House Committee on Energy and Commerce.
lower
Sep 15, 2022
Introduced
Introduced in House
lower
1 primary · 1 co-sponsor

Sponsors